Loading…
S. 2426119th CongressIn committeeLatest action Jul 24, 2025Decoded by AI · checked against the record
Official title: Equitable Community Access to Pharmacist Services Act
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
Starting in 2026, Medicare Part B would directly pay pharmacists for testing and treating COVID-19, flu, RSV, and strep throat.
45-second read · 4 questions answered below
This bill would let Medicare Part B pay pharmacists directly for testing and treating patients for COVID-19, flu, RSV, and strep throat, plus services during declared public health emergencies. Pharmacists would still need to follow state rules, which may require physician supervision or collaboration. Payment would be 80% of actual charge or 85% of the standard Medicare physician rate (100% during emergencies), with no balance billing allowed, starting January 1, 2026.
Medicare patients, typically those 65 and older or with certain disabilities, who could seek testing and treatment at pharmacies. Pharmacists and physicians who may work under new payment and collaboration arrangements are also affected.
The change would shift where and how certain Medicare patients access testing and treatment for common illnesses, moving some care from doctor's offices to pharmacies. It would also formalize payment arrangements between pharmacists and Medicare that don't currently exist.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Read twice and referred to the Committee on Finance. (text: CR S4701)